Smart Drug Delivery Systems Redefine Healthcare Innovation
Smart Drug Delivery Systems: Emerging Market Trends Driven by technical developments and a growing need for customised treatment alternatives, the global healthcare industry is changing quickly. Among the creative developments, smart drug delivery systems (SDDS) have emerged as a major one. Transforming the delivery of medicines, particularly for chronic and complex diseases like neurological […]
Interview with Laurent Van Lerberghe and David Buller, Managing Partners, KELES
In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights into the role of ethical AI in business, challenges in transparency and accountability, compliance with evolving […]
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
Martigny, Switzerland. Dijon, France – Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services (www.oncodesign-services.com), a leading CRO specialized in drug discovery and preclinical services, announce the execution of a license agreement for the use of the AbYlink™ technology for preclinical services. AbYlink™ […]
Сумма инвестиций в фармотрасль достигнет $40 млн до конца 2030 года
Около 5 млн долларов инвестировала иностранная компания AstraZeneca Kazakhstan в развитие нашей фармацевтической индустрии. Об этом на встрече с Премьер-министром сообщила директор компании, передает «24KZ». До 2030 года сумма инвестиций достигнет 40 млн долларов. А первую партию товара выпустят через месяц. Как отмечают инвесторы, поддержка со стороны государства вызывает заинтересованность в открытии производств в Казахстане. […]
Roche Looks to Expand its Drug Production in the US
Roche is planning to expand its drug production in the US and has announced a pledge to spend $50 billion in the next five years on new as well as existing manufacturing facilities across several states. This investment promise is coming at a time when the Trump administration’s tariff policies have thrown the global trade […]
Regulatory Changes in Europe Impact APIs and Excipients
There have been big changes in the pharmaceutical industry because of regulatory changes in Europe that are meant to make drugs safer, more effective, and last longer. Specialised excipients and active pharmaceutical ingredients (APIs), which are important parts of making drugs, have been at the centre of these changes. They are part of a larger […]
Green Chemistry in EU Shapes Pharmaceutical Intermediates
Green chemistry is a cutting-edge scientific discipline that focuses on developing environmentally friendly and sustainable chemical processes. In the pharmaceutical industry, it has been gaining significant interest. Green chemistry in EU is transforming the production and usage of pharmaceutical intermediates, which are essential components of medicine manufacturing, where stringent environmental regulations and sustainability goals are […]
Reviving Old Drugs with Specialty Intermediates in Europe
Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the discovery of novel molecules. Advances in specialty intermediates, which are essential for repurposing older molecules to satisfy new therapeutic requirements and regulatory constraints, have been the driving force behind […]
Specialty Chemicals Solubility Enhances Drug Formulations
The need to improve the effectiveness, safety, and accessibility of drugs drives research and innovation in the ever-evolving pharmaceutical industry. The problem of solubility and bioavailability, which affect how well a medication reaches its intended biological target after oral delivery, is one of the most important issues facing drug developers. Because of their unique qualities […]
AI in Specialty Chemicals is Advancing Innovation
The pharmaceutical specialty chemical industry is in the process of a seismic upheaval, powered by the revolutionary potential of artificial intelligence (AI). With its ability to read through huge sets of data, recognize patterns, and automate functions, AI in specialty chemicals is a game-changer for manufacturers that are especially tailored for the pharmaceutical industry. These […]
